Literature DB >> 25062114

Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer.

M Robyn Andersen1, Jason Thorpe2, Diana S M Buist3, J David Beatty4, Kate Watabayashi2, Nancy Hanson5, Robert Resta5, Jessica Chubak6, Nicole Urban1.   

Abstract

Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% reported use of genetic counseling, and knowledge of elevated risk of ovarian cancer was low. Prior genetic counseling was associated with greater perceived risk for ovarian cancer. Results suggest that most high-risk women (>75%) do not know their risk for ovarian cancer. Identification of potentially high-risk women for referral to genetic counseling may improve informed ovarian cancer risk management.

Entities:  

Keywords:  breast cancer risk; genetics; ovarian cancer; worry

Mesh:

Year:  2014        PMID: 25062114      PMCID: PMC4469617          DOI: 10.1080/08964289.2014.947234

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  27 in total

Review 1.  Screening for ovarian cancer.

Authors:  Janiel Marie Cragun
Journal:  Cancer Control       Date:  2011-01       Impact factor: 3.302

2.  Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.

Authors:  Diane Stirling; D Gareth R Evans; Gabriella Pichert; Andrew Shenton; Elaine N Kirk; Sylvia Rimmer; C Michael Steel; Sheila Lawson; R M Camille Busby-Earle; Jane Walker; Fiona I Lalloo; Diana M Eccles; Anneke M Lucassen; Mary E Porteous
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

3.  Changes in cancer worry associated with participation in ovarian cancer screening.

Authors:  M Robyn Andersen; Charles W Drescher; Yingye Zheng; Deborah J Bowen; Susan Wilson; Alicia Young; Martin McIntosh; Barry S Mahony; Kimberly A Lowe; Nicole Urban
Journal:  Psychooncology       Date:  2007-09       Impact factor: 3.894

4.  Accuracy of self-report of mammography and Pap smear in a low-income urban population.

Authors:  P G McGovern; N Lurie; K L Margolis; J S Slater
Journal:  Am J Prev Med       Date:  1998-04       Impact factor: 5.043

Review 5.  Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.

Authors:  Jonathan S Berek; Eva Chalas; Mitchell Edelson; David H Moore; William M Burke; William A Cliby; Andrew Berchuck
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

Review 6.  Hereditary breast and ovarian cancer: review and future perspectives.

Authors:  Michael P Lux; Peter A Fasching; Matthias W Beckmann
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

Review 7.  Prevention and early detection of ovarian cancer: mission impossible?

Authors:  Robert C Bast; Molly Brewer; Changping Zou; Mary A Hernandez; Mary Daley; Robert Ozols; Karen Lu; Zhen Lu; Donna Badgwell; Gordon B Mills; Steven Skates; Zhen Zhang; Dan Chan; Anna Lokshin; Yinhua Yu
Journal:  Recent Results Cancer Res       Date:  2007

Review 8.  SGO White Paper on ovarian cancer: etiology, screening and surveillance.

Authors:  John O Schorge; Susan C Modesitt; Robert L Coleman; David E Cohn; Noah D Kauff; Linda R Duska; Thomas J Herzog
Journal:  Gynecol Oncol       Date:  2010-08-07       Impact factor: 5.482

9.  Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

Authors:  T S Frank; S A Manley; O I Olopade; S Cummings; J E Garber; B Bernhardt; K Antman; D Russo; M E Wood; L Mullineau; C Isaacs; B Peshkin; S Buys; V Venne; P T Rowley; S Loader; K Offit; M Robson; H Hampel; D Brener; E P Winer; S Clark; B Weber; L C Strong; A Thomas
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

10.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Authors:  Saundra S Buys; Edward Partridge; Amanda Black; Christine C Johnson; Lois Lamerato; Claudine Isaacs; Douglas J Reding; Robert T Greenlee; Lance A Yokochi; Bruce Kessel; E David Crawford; Timothy R Church; Gerald L Andriole; Joel L Weissfeld; Mona N Fouad; David Chia; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Patricia Hartge; Paul F Pinsky; Claire S Zhu; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; Jian-Lun Xu; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-06-08       Impact factor: 157.335

View more
  3 in total

1.  Women with Family History of Breast Cancer: How Much Are They Aware of Their Risk?

Authors:  Memnun Seven; Gülcan Bağcivan; Aygul Akyuz; Ferdağ Bölükbaş
Journal:  J Cancer Educ       Date:  2018-08       Impact factor: 2.037

2.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

3.  Nursing Students' Awareness about the Warning Signs of Cancer.

Authors:  Hatice Karabuga Yakar; Sıdıka Oguz; Nuriye Öktem; Serbülent Yürük
Journal:  Asia Pac J Oncol Nurs       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.